The flavouring phytochemical 2-pentanone reduces prostaglandin production and COX-2 expression in colon cancer cells.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractMany phytochemicals found in the diet may prevent colon carcinogenesis by affecting biochemical processes in the colonic mucosa. Inflammation and subsequent elevation of the enzyme cyclooxygenase-2 (COX-2) are two such factors involved in the development of colon cancer, and inhibition of these processes could be important targets for chemoprevention. We have previously shown COX-2 inhibitory activity locally in the colon; e.g. in human fecal water from a group of vegetarians. In this study we focus on 2-pentanone, a frequently occurring compound in common foods such as banana and carrot. The aim was to study the inhibitory effects on prostaglandin production and COX-2 protein expression in tumour necrosis factor-alpha stimulated colon cancer cells (HT29) by radioimmunoassay and Western blotting. 2-Pentanone inhibited both prostaglandin production and COX-2 protein expression in human colon cancer cells. A concentration of 400 mumol/l 2-pentanone inhibited the prostaglandin production by 56.9+/-12.9% which is in the same range as the reference compound NS398 (59.8+/-7.6%). The two highest concentrations of 2-pentanone were further analyzed by Western blot, and 400 micromol/l and 200 micromol/l 2-pentanone resulted in a 53.3+/-9.6% and +/-27.1% reduction of the COX-2 protein levels respectively. Further studies on flavouring compounds, for example 2-pentanone, as colon cancer chemopreventives would be very valuable, and such results may contribute to future dietary recommendations.
CitationBiol. Pharm. Bull.. 2008, 31 (3):534-537
SponsorsSupported by grants from Agricultural Sciences and Spatial Planning (FORMAS), Swedish Cancer Society, and Stiftelsen Ruth och Richard Julins Fond. This work was partly supported by ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: “Food Quality and Safety” (Contract No. 513943). Special thanks are due to Uddeholms Aktiebolags stipendiefond for the grant to Jenny Pettersson. The authors also want to thank Dr. Ulrika Huss for helpful discussion.
- Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds.
- Authors: Karlsson PC, Huss U, Jenner A, Halliwell B, Bohlin L, Rafter JJ
- Issue date: 2005 Oct
- Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro.
- Authors: Guo W, Nie L, Wu D, Wise ML, Collins FW, Meydani SN, Meydani M
- Issue date: 2010
- The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
- Authors: Zhang H, Ye Y, Bai Z, Wang S
- Issue date: 2008 Aug
- Levamisole modulates prostaglandin E2 production and cyclooxygenase II gene expression in human colonic cancer cells.
- Authors: Liu CY, Lai YY, Lo CJ
- Issue date: 2004 Apr
- Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells.
- Authors: Tominaga K, Higuchi K, Sasaki E, Suto R, Watanabe T, Fujiwara Y, Oshitani N, Matsumoto T, Kim S, Iwao H, Arakawa T
- Issue date: 2004 Jul